Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis.
Chemokines (chemoattractant cytokines) attract and activate specific leukocyte subsets. With regard to their expression by brain parenchymal cells, they may represent the key molecules that control leukocyte entry into the subarachnoid space. In order to evaluate the contribution of chemokines in vivo, we determined the levels of MCP-1, MIP-1alpha, RANTES, IL-8, as well as of the sIL-2R in three patients with proven herpes simplex encephalitis type 1 (HSE-1). CSF samples were drawn by a subarachnoid catheter system throughout the time course of hospitalisation. Results were compared to chemokine levels in serum drawn in parallel. The clinical status was documented by the Modified Barthel Index and correlated with chemokine levels in the CSF. The results were compared with the chemokine levels in the CSF of 17 control patients with normal CSF routine parameters. High chemokine levels were detectable in the CSF of all HSE-patients. MCP-1 peak levels were found at the time of admission, while maximal IL-8 levels occurred 4 to 8 h later. The levels of MIP-1alpha and RANTES were lower than those of MCP-1 with a maximum at the time of admission. In all patients the levels of the sIL-2R increased later in the time course, at 14 to 20 h after admission. When the levels of MCP-1 were compared with the clinical status by Modified Barthel Index, we found a high reciprocal correlation (r=-0.82). Routine CSF parameters, such as leukocytes, albumin and immunoglobulins did not correlate with the clinical status. Chemokine levels in serum were found to be close to the detection limits of the ELISA systems. Our data suggest that chemokines play an important role in the pathogenesis of HSE. They may be useful parameters to monitor the stage and severity of the disease. The late increase of sIL2-R levels may indicate the beginning of the reconstitution phase.
Rösler
A
A
Department of Neurology, Philipps University, Marburg, Germany. roeslera@uni-marburg.de
Pohl
M
M
Braune
H J
HJ
Oertel
W H
WH
Gemsa
D
D
Sprenger
H
H
D002452:Cell Count; D002555:Cerebrospinal Fluid / Q000166:cytology; D018932:Chemokine CCL2 / Q000097:blood / Q000134:cerebrospinal fluid; D054405:Chemokine CCL3; D054407:Chemokine CCL4; D018946:Chemokine CCL5 / Q000097:blood / Q000134:cerebrospinal fluid; D018925:Chemokines / Q000097:blood* / Q000134:cerebrospinal fluid*; D018792:Encephalitis, Viral / Q000276:immunology / Q000473:pathology*; D006561:Herpes Simplex / Q000276:immunology / Q000473:pathology*; D018259:Herpesvirus 1, Human / Q000276:immunology*; D006801:Humans; D007136:Immunoglobulins / Q000097:blood / Q000134:cerebrospinal fluid; D016209:Interleukin-8 / Q000097:blood / Q000134:cerebrospinal fluid; D019402:Macrophage Inflammatory Proteins / Q000097:blood / Q000134:cerebrospinal fluid; D015375:Receptors, Interleukin-2 / Q000032:analysis; D012709:Serum Albumin / Q000134:cerebrospinal fluid; D013997:Time Factors
D018932:Chemokine CCL2; D054405:Chemokine CCL3; D054407:Chemokine CCL4; D018946:Chemokine CCL5; D018925:Chemokines; D007136:Immunoglobulins; D016209:Interleukin-8; D019402:Macrophage Inflammatory Proteins; D015375:Receptors, Interleukin-2; D012709:Serum Albumin